NXTS (Nexentis Technologies) 3-1 Month Momentum %: -65.18% (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NXTS Nexentis Technologies Inc NXTS
37 GF Score
Price $1.88
GF Value $3.38
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Nexentis Technologies 3-1 Month Momentum %?

Nexentis Technologies NXTS +2.17% 37 3-1 Month Momentum % is -65.18% as of Aug. 27, 2026. GuruFocus rates NXTS with a GF Score™ of 37/100 and a GF Value™ of $3.38 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 273 Agriculture companies, Nexentis Technologies ranks worse than 100% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-27), Nexentis Technologies's 3-1 Month Momentum % is -65.18%.

The industry rank for Nexentis Technologies's 3-1 Month Momentum % or its related term are showing as below:

NXTS's 3-1 Month Momentum % is ranked worse than
100% of 273 companies
in the Agriculture industry
Industry Median: -8.69 vs NXTS: -65.18

Nexentis Technologies  (NAS:NXTS) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Nexentis Technologies 3-1 Month Momentum % Related Terms


NXTS vs PUBC, ENFY, GNVR: 3-1 Month Momentum % Comparison

For the Agricultural Inputs subindustry, Nexentis Technologies's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nexentis Technologies 3-1 Month Momentum % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Nexentis Technologies's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Nexentis Technologies's 3-1 Month Momentum % falls into.


NXTS
37GF Score
Nexentis Technologies Inc NXTS
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexentis Technologies  (NAS:NXTS) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -65.18% mean?
Nexentis Technologies (NXTS) has a 3-1 Month Momentum % of -65.18% as of Aug. 27, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Nexentis Technologies and its competitors. According to the industry distribution chart, Nexentis Technologies ranks #273 out of 273 companies in the Agriculture industry.
Is Nexentis Technologies' 3-1 Month Momentum % too high?
Nexentis Technologies' current 3-1 Month Momentum % is -65.18%. Based on the distribution chart, Nexentis Technologies ranks #273 out of 273 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Nexentis Technologies has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexentis Technologies' 3-1 Month Momentum % compare to PUBC and ENFY?
According to the Agriculture industry distribution chart, Nexentis Technologies ranks #273 out of 273 companies for 3-1 Month Momentum %. This places Nexentis Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for an Agriculture company?
A good 3-1 Month Momentum % depends on the Agriculture industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Nexentis Technologies and its competitors. Nexentis Technologies's current 3-1 Month Momentum % is -65.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexentis Technologies stock overvalued right now?
Based on GuruFocus' analysis, Nexentis Technologies (NXTS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.38, compared to a current price of $1.88 — trading 44.4% below its estimated fair value. The current 3-1 Month Momentum % is -65.18%. Nexentis Technologies' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Nexentis Technologies (NXTS), the current 3-1 Month Momentum % is -65.18% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nexentis Technologies (NXTS) Overvalued in 2026?

Based on GuruFocus' analysis, Nexentis Technologies stock appears to be undervalued. The current stock price of $1.88 is trading 44.4% below its estimated GF Value™ of $3.38. GuruFocus considers Nexentis Technologies to be Possible Value Trap.

Key valuation signals for NXTS:

  • 3-1 Month Momentum %: -65.18%
  • GF Value™: $3.38 vs. price of $1.88 (44.4% below fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the NXTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nexentis Technologies Business Description

Address Pinhas Sapir Street 3, Kiryat HaMada, Ness Ziona, ISR, 7403626
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
37GF Score

Get the complete analysis for NXTS

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.88
Price
$3.38
GF Value